$INSY Monday, February 19, 2018 Share price has not rebounded from the last week of at/below $8/share trading. I believe the stock is still a terrific buy at this level. I also anticipate some more roller-coastering over the next few weeks as investors are still not fully onboard with the new Executive Management of INSYS Therapeutics.
I am looking for some closure on the court cases AND the approvals and releases of additional medications from INSYS. I fully expect a little Bad News but I also anticipate that there will be more Good News that will create a BUY atmosphere for INSY stock.
I am still very positive on this stock.
(0)
(0)
Insys Therapeutics Inc. (INSYQ) Stock Research Links